Bariatric denied as not FDA-approved for this use by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for bariatric are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UHC Denied Your Bariatric Procedure as "Not FDA-Approved" — and How to Respond

A "not FDA-approved" denial for bariatric surgery most often targets a specific device, implant, or procedural component rather than the surgery as a whole. The most established bariatric surgical procedures are performed using FDA-cleared or FDA-approved tools, and the surgeries themselves do not require FDA approval as procedures. This denial is most likely to appear when: a newer intragastric balloon system, an implantable device, or a procedural accessory is involved and UHC's policy has not been updated to reflect its current regulatory status; or when the claim includes a device component that carries 510(k) clearance but is not explicitly named in UHC's coverage policy.

## Federal Appeal Rights

• Internal appeal (ERISA §503 / ACA §2719) — File within the timeframe stated on your denial letter. UHC must decide within 30 days (pre-service) or 60 days (post-service).
• External review — After exhausting internal appeals, you have approximately 4 months to request independent external review. The IRO will assess whether UHC's determination is consistent with current regulatory facts and accepted medical practice. Expedited review is available when delay threatens your health.

## Documentation to Gather

• FDA clearance or approval documentation for the specific device or procedural component at issue — your bariatric surgeon or the device manufacturer's medical affairs department can supply the 510(k) clearance letter or PMA approval.
• UHC's current coverage policy for the specific procedure or device — identify the exact language used to deny coverage and whether it references FDA status explicitly.
• Your surgeon's letter confirming FDA clearance of the device used and explaining that the procedure is within accepted standard of care.
• Operative report or planned procedure description with the specific device model and manufacturer identified.

## Criteria-Mapping Structure

| UHC Denial Basis | Your Response Evidence | |---|---| | Device lacks FDA approval/clearance | [FDA 510(k) number or PMA approval reference + manufacturer documentation] | | Procedure not performed with FDA-approved device | [Operative report identifying cleared device; surgeon attestation] | | Coverage policy not updated to reflect device status | [UHC policy version date vs. FDA clearance date — show clearance predates policy review] |

## Key Appeal Argument

The FDA clearance document is dispositive evidence. If the device or implant carries current FDA 510(k) clearance or PMA approval, UHC's "not FDA-approved" denial reason is factually unsupported. Lead your appeal letter with the FDA document as Exhibit A, state the specific clearance or approval number, and request that UHC identify precisely which component it contends lacks clearance — shifting the burden of specificity back to the insurer.